US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,350.48

+15.701.18%

Number of Gainers:18

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,356.52

Open:1,334.85

Low:1,334.85

Close:1,334.78

Loading ...

Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell

MT Newswires Live

Abbott Laboratories : Oppenheimer Raises Target Price to $140 From $134

THOMSON REUTERS

Almonty Industries to Participate in Planet MicroCap Showcase on April 23-24, 2025

BioNTech Se : Leerink Partners Cuts Target Price to $112 From $121

THOMSON REUTERS

BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead

THOMSON REUTERS

Bank of America Securities Remains a Buy on BioNTech SE (BNTX)

SAP SE (0NW4): New Buy Recommendation for This Technology Giant

BUZZ-Street View: Abbott's effective management could help it triumph over tariffs

Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC)

Abbott : Jefferies Raises Target Price to $137 From $135

THOMSON REUTERS

Abbott : Btig Raises Target Price to $145 From $140

THOMSON REUTERS

Abbott : Piper Sandler Raises Target Price to $145 From $133

THOMSON REUTERS

Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know

BRIEF-ACIP Votes To Expand Recommendation For Pfizer’S RSV Vaccine Abrysvo To Include Adults Aged 50 To 59 At Increased Risk Of Disease

ACIP votes to expand recommendation for Pfizer’s RSV vaccine

Acip Votes to Expand Recommendation for Pfizer’s Rsv Vaccine Abrysvo® to Include Adults Aged 50 to 59 at Increased Risk of Disease

THOMSON REUTERS

ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease

Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1350.4775,"timestamp":1745351999999,"preClose":1334.7778,"halted":0,"volume":89340824,"delay":0,"changeRate":0.011762,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":15.699707,"latestTime":"04-22 16:00:00 EDT","open":1334.8547,"high":1356.5189,"low":1334.8547,"amount":4208127625.527641,"amplitude":0.016231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.67431,"peRate":24.399045,"turnoverRate":0.005758,"increases":18,"decrements":2,"flats":0,"marketCap":1116116120071,"floatMarketCap":1096270001421.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1356.5189,"amplitude":0.016231,"preClose":1334.7778,"low":1334.8547,"pbRate":"3.67431","latestPrice":1350.4775,"volume":89340824,"delay":0,"open":1334.8547,"prevYearClose":1274.8187,"prevWeekClose":1341.7848,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1332.2346,"twentyDayClose":1413.1478,"sixtyDayClose":1318.7274,"secType":"PLATE","market":"US","turnoverRate":0.005758,"peRate":24.399045,"marketCap":1116116120071,"floatMarketCap":1096270001421.5,"timestamp":1745351999999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":18,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528711090","title":"Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711090","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528711090?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:33","pubTimestamp":1744893215,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Thursday that the US Food and Drug Administration has cleared an investigational new drug application for its oral IRAK4 degrader GS-6791/NX-0479, allowing for a phase 1 trial to start, which is expected to begin in Q2.The company said it is to receive $5 million from Gilead Sciences  for the IND clearance and remains eligible for up to $420 million in potential future milestone payments as part of a 2019 collaboration agreement.Nurix said GS-6791/NX-0479 has potential applications in rheumatology and dermatology, including rheumatoid arthritis and atopic dermatitis.Under the terms of the 2019 collaboration agreement, Nurix and Gilead Sciences  are looking to discover, develop, and commercialize a pipeline of up to five therapies for cancer and other diseases, the company said.Nurix shares were over 8% higher while Gilead shares were 0.2% higher in recent premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4568","BK4578","LU0109394709.USD","LU2089984988.USD","LU0234570918.USD","LU1839511570.USD","LU2468319806.SGD","LU0889565916.HKD","BK4588","BK4550","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","43A.SI","LU2087621335.USD","BK4585","BK6520","LU1066051498.USD","LU0320765992.SGD","LU1430594728.SGD","LU1066053197.SGD","NRIX","BK4139","IE0002270589.USD","GILD","IE00B7SZLL34.SGD","LU1571399168.USD","BK4566","IE00B3T34201.USD","BK6054","BK4532","IE00BZ1G4Q59.USD","LU1585245621.USD","BK4583"],"gpt_icon":0},{"id":"2528719490","title":"Abbott Laboratories : Oppenheimer Raises Target Price to $140 From $134","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528719490?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:18","pubTimestamp":1744892284,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nAZN3Q3F2M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237957811.SGD","LU2237957902.USD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1989763427.SGD","IE00B4R5TH58.HKD","LU0266013472.USD","LU1721429402.USD","IE0009355771.USD","LU0122379950.USD","LU2133065610.SGD","BK4581","BK4585","LU1914381329.SGD","LU0234572021.USD","LU2468319806.SGD","SG9999002232.USD","SG9999004303.SGD","LU1989763690.USD","IE00BJT1NW94.SGD","BK4588","BK4568","LU1061106388.HKD","BK4592","ABT","BK4566","IE0002141913.USD","LU1721429741.USD","LU2112291526.USD","SGXZ23171101.USD","BK4082","LU1691799644.USD","SG9999002224.SGD","LU0868494617.USD","LU0170899867.USD","BK4504","LU1057294990.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4533","LU2089984988.USD"],"gpt_icon":0},{"id":"2528719737","title":"Almonty Industries to Participate in Planet MicroCap Showcase on April 23-24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719737","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528719737?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"TORONTO, April 17, 2025----Almonty Industries Inc.     , a leading global producer of tungsten concentrate, today announced that management has been invited to present at the 2025 Planet MicroCap Showcase taking place in Las Vegas, Nevada on April 23-24, 2025.Business Development and Financial Planning Officer Sophie Frédérique Wind-Veeser is scheduled to host a presentation as well as one-on-one meetings with institutional investors throughout the event as follows:. Lewis Black, President & CEO of Almonty, commented: \"We are pleased to participate in the 2025 Planet MicroCap Showcase as part of our ongoing investor engagement strategy. This comes at an exciting time for Almonty as we approach the operational startup of the Sangdong Tungsten Mine in South Korea and advance our U.S. domestication. With growing global demand for secure tungsten and molybdenum supply chains, Almonty is well-positioned to capitalize on these trends. We look forward to sharing our progress with institutiona","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/almonty-industries-participate-planet-microcap-120000729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4168","APT","ALMTF","AII.AU","BK4568","BK4086","APT.AU","BK7095"],"gpt_icon":0},{"id":"2528671599","title":"BioNTech Se : Leerink Partners Cuts Target Price to $112 From $121","url":"https://stock-news.laohu8.com/highlight/detail?id=2528671599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528671599?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:44","pubTimestamp":1744890242,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV2N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4585","BK4588","BK4568","BNTX","BK4551","BK4139","BK4548"],"gpt_icon":0},{"id":"2528790993","title":"BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479","url":"https://stock-news.laohu8.com/highlight/detail?id=2528790993","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528790993?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:04","pubTimestamp":1744887869,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479 April 17 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR GS-6791/NX-0479 - A N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7XL3YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3B42.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4585","LU0234570918.USD","GILD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4583","BK4550","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","BK4532","LU0109394709.USD","LU1571399168.USD","NRIX","LU2087621335.USD","BK4566","LU1585245621.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","LU2468319806.SGD","BK4568","IE0002270589.USD","BK4578","LU0320765992.SGD"],"gpt_icon":0},{"id":"2528797017","title":"Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797017?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7XL3YT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU0289739699.SGD","BK4532","BK4583","LU1571399168.USD","BK4139","LU0320765992.SGD","IE00BKVL7J92.USD","LU1585245621.USD","LU1066053197.SGD","LU2087621335.USD","LU2089984988.USD","LU1430594728.SGD","BK4585","BK4588","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4578","LU1839511570.USD","LU0109394709.USD","LU0058720904.USD","BK4568","LU2468319806.SGD","IE0002270589.USD","LU1066051498.USD","BK4566","NRIX","BK4550","LU0889565916.HKD","IE00B3T34201.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2528740797","title":"Bank of America Securities Remains a Buy on BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528740797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528740797?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:58","pubTimestamp":1744887513,"startTime":"0","endTime":"0","summary":"In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on BioNTech SE (BNTX – Research Report), with a pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-biontech-se-bntx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-biontech-se-bntx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","IE00B7SZLL34.SGD","LU0306806265.USD","LU1883839398.USD","LU1791807156.HKD","LU1074936037.SGD","BK4207","LU1718418525.SGD","BK4551","IE00BBT3K403.USD","LU0208291251.USD","IE00B19Z3581.USD","LU0648001328.SGD","BK4581","LU0053666078.USD","BK4568","LU0070302665.USD","LU1880398554.USD","LU0971096721.USD","LU1880398471.USD","LU2129689514.USD","IE00BLSP4452.SGD","LU2129689605.HKD","LU0320765489.SGD","LU0417517546.SGD","BNTX","BK4534","LU0314106906.USD","LU1201861165.SGD","LU1280957306.USD","LU1668664300.SGD","LU0868494617.USD","BK4553","LU0106831901.USD","BK4504","IE00BFXG1179.USD","BK4588","LU0310800965.SGD","LU0149725797.USD","LU1894683348.USD","LU0477156797.USD","LU2129689431.USD","LU2133065610.SGD","LU0098860793.USD","LU1366192091.USD","LU0683600562.USD","BK4585","LU0787776722.HKD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2528879125","title":"SAP SE (0NW4): New Buy Recommendation for This Technology Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=2528879125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528879125?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:18","pubTimestamp":1744885119,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Wolf from Warburg Research maintained a Buy rating on SAP SE (0NW4 – Research Report), with a price target of €...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sap-se-0nw4-new-buy-recommendation-for-this-technology-giant-29?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sap-se-0nw4-new-buy-recommendation-for-this-technology-giant-29?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTX","BK4568","BK4551","BK4139","BK4585","BK4535","BK4548","BK4588"],"gpt_icon":0},{"id":"2528760455","title":"BUZZ-Street View: Abbott's effective management could help it triumph over tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2528760455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528760455?lang=en_us&edition=fundamental","pubTime":"2025-04-17 17:16","pubTimestamp":1744881378,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Abbott's effective management could help it triumph over tariffs** Medical device maker Abbott Laboratories ABT.N maintained its annual profit forecast on Wednesday and said it expected U.S. tariffs to hit earnings by a \"few hundred million dollars\"** Median PT of 28 brokerages covering the stock is $145 - LSEG dataOPTIMISM FOR MEDTECH** J.P.Morgan  says it is optimistic about co, citing strong fundamentals and effective management to mitigate tariff impacts** Piper Sandler  says it is confident in co's diversified business model and its ability to navigate through periods of uncertainty while delivering sustainable growth** TD Cowen  sees co mitigating tariff impacts through strategic manufacturing adjustments and leveraging past successes** \"We saw ABT rapidly respond to the COVID pandemic and build a multi billion-dollar Covid testing franchise in very little time. This precedent should give investors confidence that the plant optimization initiatives can succeed i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV0FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","LU2237957811.SGD","IE00B4R5TH58.HKD","BK4581","IE00BJT1NW94.SGD","BK4592","IE00B2B36J28.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999002232.USD","LU1023059063.AUD","LU2089984988.USD","BK4568","SGXZ23171101.USD","BK4082","IE0002141913.USD","LU2237957902.USD","LU0266013472.USD","LU0122379950.USD","ABT","LU1057294990.SGD","LU0868494617.USD","SG9999004303.SGD","LU2112291526.USD","BK4566","BK4585","IE0009355771.USD","LU0234572021.USD","BK4533","LU1691799644.USD","LU1721429402.USD","LU1989763427.SGD","LU2133065610.SGD","BK4504","LU1721429741.USD","BK4588","LU1061106388.HKD","LU0170899867.USD","LU1989763690.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2528505762","title":"Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2528505762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528505762?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:45","pubTimestamp":1744879548,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their neutral stance on MRNA stock, giving a Hold rating on April 14. Myles Minter has given his ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/modernas-market-challenges-hold-rating-amid-regulatory-uncertainty-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/modernas-market-challenges-hold-rating-amid-regulatory-uncertainty-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","MRNA","BK4548","BK4533","BK4568","BK4501","BK4585","BK4588","BK4532","BK4139","BK4534"],"gpt_icon":0},{"id":"2528765220","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528765220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528765220?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:11","pubTimestamp":1744877473,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abbott Laboratories (ABT – Research Report) and Bl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-blueprint-medicines-bpmc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-blueprint-medicines-bpmc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU1691799644.USD","SG9999002224.SGD","BK4082","LU2237957811.SGD","SG9999002232.USD","BPMC","LU1914381329.SGD","IE00B4R5TH58.HKD","HCSG","LU0868494617.USD","LU0170899867.USD","BK4588","LU1989763690.USD","SG9999004303.SGD","IE00BJJMRZ35.SGD","LU1989763427.SGD","LU2468319806.SGD","LU1023059063.AUD","LU1057294990.SGD","BK4137","BK4585","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1721429741.USD","BK4504","LU2237957902.USD","BK4581","SGXZ23171101.USD","IE00BFTCPJ56.SGD","ABT","LU0266013472.USD","LU1061106388.HKD","BK4566","LU0234572021.USD","LU2133065610.SGD","BK4139","LU1721429402.USD","BK4592","BK4533","LU0122379950.USD","BK4505","BK4568","LU2089984988.USD","LU0053671581.USD","IE0009355771.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2528751366","title":"Abbott : Jefferies Raises Target Price to $137 From $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2528751366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528751366?lang=en_us&edition=fundamental","pubTime":"2025-04-17 14:40","pubTimestamp":1744872035,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4504","LU1914381329.SGD","LU2237957811.SGD","SGXZ23171101.USD","IE00BFTCPJ56.SGD","BK4082","BK4585","LU1057294990.SGD","IE0002141913.USD","LU2089984988.USD","LU2468319806.SGD","BK4581","IE00B2B36J28.USD","LU1691799644.USD","LU1989763690.USD","LU1989763427.SGD","BK4533","BK4588","IE00B4R5TH58.HKD","LU2112291526.USD","LU1061106388.HKD","LU0868494617.USD","LU1721429402.USD","LU1721429741.USD","IE0009355771.USD","BK4566","LU0234572021.USD","SG9999002224.SGD","IE00BJT1NW94.SGD","LU2133065610.SGD","LU0170899867.USD","ABT","BK4568","LU1023059063.AUD","LU0122379950.USD","LU2237957902.USD","BK4592","SG9999002232.USD","LU0266013472.USD","IE00BJJMRZ35.SGD","SG9999004303.SGD"],"gpt_icon":0},{"id":"2528758730","title":"Abbott : Btig Raises Target Price to $145 From $140","url":"https://stock-news.laohu8.com/highlight/detail?id=2528758730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528758730?lang=en_us&edition=fundamental","pubTime":"2025-04-17 13:24","pubTimestamp":1744867470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","ABT","SG9999002232.USD","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2237957811.SGD","BK4585","LU1057294990.SGD","SG9999002224.SGD","IE0002141913.USD","BK4581","LU0868494617.USD","LU1061106388.HKD","LU2112291526.USD","BK4568","LU2237957902.USD","BK4533","LU2468319806.SGD","LU1691799644.USD","IE0009355771.USD","LU1989763690.USD","LU0122379950.USD","BK4504","LU1721429402.USD","SG9999004303.SGD","BK4592","IE00B2B36J28.USD","BK4566","IE00BJT1NW94.SGD","LU1721429741.USD","LU2089984988.USD","LU2133065610.SGD","IE00B4R5TH58.HKD","LU0170899867.USD","LU0266013472.USD","LU1989763427.SGD","SGXZ23171101.USD","LU0234572021.USD","BK4588","BK4082"],"gpt_icon":0},{"id":"2528732860","title":"Abbott : Piper Sandler Raises Target Price to $145 From $133","url":"https://stock-news.laohu8.com/highlight/detail?id=2528732860","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528732860?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:08","pubTimestamp":1744862907,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV044:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1721429741.USD","LU1023059063.AUD","LU1061106388.HKD","LU0170899867.USD","BK4082","LU2133065610.SGD","SGXZ23171101.USD","ABT","LU1721429402.USD","SG9999002224.SGD","BK4581","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4533","BK4504","LU1914381329.SGD","LU1691799644.USD","LU0234572021.USD","LU1989763427.SGD","LU0266013472.USD","BK4566","SG9999004303.SGD","IE00BJT1NW94.SGD","BK4592","BK4568","LU2237957811.SGD","LU2468319806.SGD","LU2237957902.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU1057294990.SGD","LU1989763690.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","SG9999002232.USD","LU2089984988.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4588"],"gpt_icon":0},{"id":"2528578599","title":"Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528578599","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528578599?lang=en_us&edition=fundamental","pubTime":"2025-04-17 06:00","pubTimestamp":1744840815,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Gilead Sciences  standing at $104.90, reflecting a -0.74% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss of 2.24%. Meanwhile, the Dow experienced a drop of 1.73%, and the technology-dominated Nasdaq saw a decrease of 3.07%.Shares of the HIV and hepatitis C drugmaker have depreciated by 4.13% over the course of the past month, outperforming the Medical sector's loss of 7.47% and the S&P 500's loss of 4.17%.Market participants will be closely following the financial results of Gilead Sciences in its upcoming release. The company plans to announce its earnings on April 24, 2025. In that report, analysts expect Gilead Sciences to post earnings of $1.73 per share. This would mark year-over-year growth of 231.06%. At the same time, our most recent consensus estimate is projecting a revenue of $6.83 billion, reflecting a 2.18% rise from the equivalent quarter last year.The Zacks Industry Rank ga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-gild-stock-moves-220015275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","BK4583","IE00BSNM7G36.USD","LU0289739699.SGD","BK4550","BK4139","IE00B19Z3B42.SGD","BK4585","BK4566","LU1066051498.USD","BK4578","IE00BKVL7J92.USD","LU0234570918.USD","BK4532","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","LU0109394709.USD","LU1585245621.USD","LU1066053197.SGD","BK4568","IE00B19Z3581.USD","IE0002270589.USD","BK4588"],"gpt_icon":0},{"id":"2528704562","title":"BRIEF-ACIP Votes To Expand Recommendation For Pfizer’S RSV Vaccine Abrysvo To Include Adults Aged 50 To 59 At Increased Risk Of Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2528704562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528704562?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:32","pubTimestamp":1744835523,"startTime":"0","endTime":"0","summary":"BRIEF-ACIP Votes To Expand Recommendation For Pfizer’S RSV Vaccine Abrysvo To Include Adults Aged 50 To 59 At Increased Risk Of DiseaseApril 16 (Reuters) - Pfizer Inc PFE.N:ACIP VOTES TO EXPAND RECOMM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUA5KWNWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0170899867.USD","LU1066051498.USD","LU0058720904.USD","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999002232.USD","LU0306807586.USD","BK4568","LU0868494617.USD","BK4533","LU1894683348.USD","LU0321505868.SGD","LU1883839398.USD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2528089912","title":"ACIP votes to expand recommendation for Pfizer’s RSV vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2528089912","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528089912?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:20","pubTimestamp":1744834835,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acip-votes-to-expand-recommendation-for-pfizers-rsv-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acip-votes-to-expand-recommendation-for-pfizers-rsv-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","PFE","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2528227722","title":"Acip Votes to Expand Recommendation for Pfizer’s Rsv Vaccine Abrysvo® to Include Adults Aged 50 to 59 at Increased Risk of Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528227722?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:15","pubTimestamp":1744834501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUA5KWNWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BBT3K403.USD","LU0306807586.USD","BK4550","IE0002270589.USD","SG9999001176.USD","LU1894683264.USD","BK4599","LU1057294990.SGD","BK4568","SG9999013999.USD","BK4534","LU0170899867.USD","LU0122379950.USD","LU0225284248.USD","LU0306806265.USD","SG9999011175.SGD","PFE","BK4585","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0058720904.USD","LU0321505439.SGD","IE00B19Z3581.USD","BK4007","LU0321505868.SGD","LU1066053197.SGD","SG9999003800.SGD","BK4592","LU1883839398.USD","LU0289739699.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4533","IE00BLSP4239.USD","LU0456855351.SGD","BK4588","LU1023059063.AUD","LU0868494617.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1066051498.USD","LU0225771236.USD","LU1894683348.USD","IE000M9KFDE8.USD","BK4581"],"gpt_icon":0},{"id":"2528920680","title":"ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2528920680","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528920680?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:15","pubTimestamp":1744834500,"startTime":"0","endTime":"0","summary":"Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74. NEW YORK, April 16, 2025----Pfizer Inc.  announced today that the U.S. Centers for Disease Control and Prevention’s  Advisory Committee on Immunization Practices  voted to expand its recommendation for the use of respiratory syncytial virus  vaccines approved for adults 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease . This includes ABRYSVO , which in October 2024, the U.S. Food and Drug Administration approved for the prevention of RSV-associated LRTD in adults aged 18 to 59 at increased risk of severe disease.ABOUT ABRYSVOPfizer currently is the only company with an RSV vaccine to help protect adults aged 60 and older, and adults 18 and older at increased risk of lower respiratory tract disease caused by RSV , as well as infants through maternal immunization. ABRYSVO is an unadjuvanted, bivalent vaccine that was designed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acip-votes-expand-recommendation-pfizer-201500828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999013999.USD","BK4555","LU1894683264.USD","LU0225771236.USD","LU0321505868.SGD","IE0002270589.USD","BK4581","PFE","IE000M9KFDE8.USD","BK4592","F","IE00BLSP4452.SGD","LU0058720904.USD","SG9999002224.SGD","SG9999002232.USD","LU0289739699.SGD","LU1023059063.AUD","LU1883839398.USD","IE00BLSP4239.USD","BK4516","BK4568","LU0306806265.USD","LU1066051498.USD","SG9999003800.SGD","LU0225284248.USD","BK4574","LU0122379950.USD","BK4550","LU1057294990.SGD","LU0868494617.USD","BK4534","IE00B19Z3581.USD","LU1894683348.USD","CDC","LU0456855351.SGD","IE00B19Z3B42.SGD","BK4585","LU0321505439.SGD","LU0234572021.USD","SG9999011175.SGD","BK4533","BK4007","BK4588","LU0306807586.USD","IE00BBT3K403.USD","SG9999001176.USD","LU1066053197.SGD","LU0985481810.HKD","LU0170899867.USD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2528279874","title":"Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula","url":"https://stock-news.laohu8.com/highlight/detail?id=2528279874","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528279874?lang=en_us&edition=fundamental","pubTime":"2025-04-17 01:47","pubTimestamp":1744825666,"startTime":"0","endTime":"0","summary":"Novavax recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, Adjuvanted, compared to Pfizer-BioNTech's offering. Despite this positive development, the company's stock performance last week was largely flat, rising 1%, amid broader market fluctuations driven by U.S. restrictions on chip exports to China. The Dow Jones, S&P 500, and Nasdaq all experienced notable declines, with technology stocks leading the downturn. In this context, the encouraging vaccine news from Novavax likely provided a stabilizing influence against broader market trends.We've spotted 2 possible red flags for Novavax you should be aware of, and 1 of them is significant.NasdaqGS:NVAX Revenue & Expenses Breakdown as at Apr 2025. With regards to Novavax's recent achievements, the preliminary SHIELD-Utah study results could positively influence revenue and earnings forecasts due to increased consumer confi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novavax-nasdaqgs-nvax-study-shows-174746964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVAX","BK4551","BK4139","BNTX","BK4568","BK4535","BK4548","BK4585","BK4588","BK4547"],"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":4,"totalSize":269,"code":"91000000","status":"200"}]}}